ScreenPoint Medical Unveils New FDA Approval to Enhance Breast Cancer Detection at RSNA At the RSNA conference, ScreenPoint Medical announces new FDA-approved features for its innovative breast cancer detection AI, Transpara, to aid radiologists.

ScreenPoint Medical Unveils New FDA Approval to Enhance Breast Cancer Detection at RSNA #USA #Chicago #RSNA_2024 #ScreenPoint_Medical #Breast_Cancer_AI